A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration

Clinical trial NCT03626636 · COMPLETED

Trial details

NCT number: NCT03626636
Sponsor: Allegro Ophthalmics, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Age-related Macular Degeneration

Start date: 2017-08-01
Primary completion: 2019-04-04
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.